AP1-Luc/EF1α-mCherry Reporter Cell Line - HepG2

HepG2 cells, originally derived from human liver tissue, represent one of the most established models for investigating hepatocyte-specific functions, drug metabolism, and toxicology due to their ability to retain a wide range of differentiated liver functions. The AP1-Luc/EF1α-mCherry Reporter Cell Line - HepG2 is a specialized genetic tool engineered for the precise monitoring of the AP-1 (Activator Protein-1) transcription factor pathway within this hepatic context. This stable cell line features a dual-reporter configuration: a firefly luciferase gene driven by a promoter containing multiple AP-1 response elements, and a constitutively expressed mCherry fluorescent protein under the control of the EF1α promoter. The integration of mCherry provides a robust internal control for normalizing experimental variability—such as cell density and viability—ensuring that the luciferase activity accurately reflects the physiological induction of the AP-1 signaling pathway.

In terms of application, this reporter cell line is indispensable for high-throughput screening (HTS) of chemical libraries and the functional validation of therapeutic candidates. Since AP-1 is a key downstream mediator of the MAPK, JNK, and ERK signaling cascades, the line is frequently utilized to assess cellular responses to growth factors, inflammatory cytokines, and various environmental stressors. It is particularly effective in identifying hepatotoxic compounds during early-stage drug development, as AP-1 activation often precedes overt cell death in response to oxidative stress or chemical insults. Beyond toxicology, the system is used to study liver-specific oncogenic processes and the efficacy of anti-inflammatory agents. The inclusion of the mCherry marker further enables long-term live-cell imaging and simplifies the identification of stable populations via flow cytometry. Together, these features provide researchers with a quantitative, sensitive, and reproducible platform for dissecting the complex regulatory networks governing liver health and disease.